Samsung Biologics-Q2 earnings
Samsung Biologics Q2 net profit up 21.6 pct to 184.9 bln won
SEOUL, July 26 (Yonhap) -- Samsung Biologics Co. on Wednesday reported its second-quarter net profit of 184.9 billion won (US$145.1 million), up 21.6 percent from a year earlier.
The company said in a regulatory filing that it posted 253.4 billion won in operating profit for the quarter, compared with 169.7 billion won a year ago. Sales rose 33 percent to 866.2 billion won.
The earnings exceeded market expectations. The average estimate of net profit by analysts stood at 171.9 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
(END)
(C) Yonhap News Agency. All Rights Reserved



















![[ENG/JPN/Full] TEMPEST(템페스트) 'In The Dark(어둠 속에서)' Showcase|As I am|한빈·형섭·혁·은찬·LEW·태래](/news/data/20251027/p179578205733686_156_h.jpg)
![[4K LIVE] TEMPEST(템페스트) 'nocturnal' Showcase Stage](/news/data/20251027/p179572206915679_655_h.jpg)




![[경주APEC]](/news/data/20251029/yna1065624915909567_172_h2.jpg)









